# Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends

> **NCT04865679** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Axogen Corporation** · enrollment: 15 (estimated)

## Conditions studied

- Symptomatic Neuroma
- Amputation
- Chronic Nerve Pain

## Interventions

- **DEVICE:** Axoguard Nerve Cap®

## Key facts

- **NCT ID:** NCT04865679
- **Lead sponsor:** Axogen Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04865679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04865679, "Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04865679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*